Re: [balita-anda] MMR dan Autism

2000-10-25 Terurut Topik Rien

sumber : www.cdc.gov

[Centers for Disease Control and Prevention]

1. Does the MMR vaccine cause autism?

CDC believes that the current scientific evidence does not support the
hypothesis that MMR, or any combination of vaccines, cause the development of
autism, including regressive forms of autism. A suspected link between MMR
vaccine and autism has been suggested by researchers and some parents of
children with autism. Often symptoms of autism are first noted by parents as
their child begins to have difficulty with delays in speaking after age one.
MMR vaccine is first given to children at 12 to 15 months of age. Therefore,
children an apparent onset of autism within a few weeks after MMR vaccination
may simply be an unrelated chance occurrence.

An extensive study of the evidence was recently conducted in the United
Kingdom. The British Committee on Safety of Medicines convened a "Working
Party on MMR Vaccine" to conduct a  systematic review of reports of autism,
gastrointestinal disease, and similar disorders after receipt of MMR or
measles/rubella vaccine. The National Childhood Encephalopathy Study (NCES)
was examined to see if there was any link between measles vaccine and
neurological events. The researchers in England found no indication that
measles vaccine contributes to the development including educational and
behavioral deficits (Miller et al 1997). A more recent epidemiological study
also found no association between MMR vaccine and autism (Taylor et al. 1999).
This study compared rates of autism between children who received the MMR
vaccine and children who did not. The results found no difference in rates of
autism between the two groups.

2. What about the study by Dr. Andrew Wakefield, of the Royal Free Hospital in
the United Kingdom?

Current scientific evidence does not support the hypothesis that the MMR
vaccine, or any combination of vaccines, causes the development of autism,
including regressive forms of autism. This includes the research conducted by
Dr. Wakefield.

The Wakefield Study

This study was conducted in 1998 and looked at whether the existence of the
measles virus from the MMR vaccine could cause bowel disease and, in turn,
cause autism. The authors reviewed reports of 12 children with bowel disease
and regressive developmental disorders, mostly autism. In 9 of the cases, the
child's parents or pediatrician speculated that the MMR vaccine had
contributed to the behavioral problems of the children in the study.

This study was reviewed by an expert committee from the UK Medical Research
Council (MRC). The Council concluded there is no evidence to link the MMR
vaccine with autism. On April 3, 2000 the MRC issued a new report confirming
its earlier conclusion; MMR has not been linked with inflammatory bowel
disease in autism. A copy of this research report can be found in the appendix
and is also available at the MRC web site, http://www.mrc.ac.uk

Limitations of Dr. Wakefield's Study

1. The study used too few cases to make any generalizations about the causes
of autism; only 12 children were included in the study. Further, the cases
were selected by researchers and may not be representative of many cases of
autism.
2. There were inadequate groups of control children. As a result, it is
difficult to determine whether the bowel changes were
similar to changes in normal children, or to determine if the rate of
vaccination in autistic children was higher than in the
general population.
3. The study did not identify the time period  during which the cases were
identified.
4. In at least 4 of the 12 cases behavioral problems appeared before the onset
of symptoms of bowel disease; that is, the
effect preceded the proposed cause. It is unlikely, therefore, that bowel
disease or the MMR vaccine triggered the autism.


3. Would it be safer to separate the MMR vaccine into its individual
components--in other words, give children three separate
shots, at different times (e.g., six months or one year apart), instead of one
combined shot? Why do we have to use the combined vaccine?

There is no scientific research or data to indicate that there is any benefit
to separating the MMR vaccine into its individual components. This idea is not
based on any published evaluation of the effect(s) it may have on children. In
fact, splitting
the MMR vaccine into three separate doses may be harmful because it would
expose children unnecessarily to potentially serious diseases. For instance,
if rubella vaccine were delayed, 4 million children would be susceptible to
rubella for an additional six to 12 months. This would potentially allow
otherwise preventable cases of congenital rubella syndrome (CRS) to occur.
Infection of pregnant woman with "wild" rubella virus is one of the few known
causes of autism. Thus, by preventing infection of pregnant women, rubella
vaccine also prevents autism.

4. Should a younger sibling, or a child of someone who suffered autism be
vaccinated with MMR or other 

Re: [balita-anda] MMR dan Autism

2000-10-25 Terurut Topik Rien

sorry, sumbernya waktu itu lupa saya catat...
Kayaknya sih dari CDC juga.

-

Frequently Asked Questions about Measles, Mumps, and Rubella, and MMR
Vaccine

[Q.]Are measles, mumps, and rubella still a problem in the United States?

All three diseases are currently at or near their lowest point ever
reported in the United States. In 1995, a provisional total of 288 measles
cases (lowest ever), 840 cases of mumps (lowest ever), and 200 cases of
rubella (third lowest) were reported.

[Q.]If the chance of the diseases is so low, why do we still give the vaccine?

Measles, mumps, and rubella are all still very common in other parts of
the world, and can be easily imported into the United States. A reduction in
our vaccination efforts would lead to a rapid increase in the number of
susceptible children, which could lead to an outbreak.

[Q.]What kind of vaccine is MMR?

MMR is a attenuated live virus vaccine. After injection, the viruses
replicate (grow), and cause a subclinical or asymptomatic infection in the
vaccinated person. The person's immune system fights the infection caused by
these weakened viruses, and immunity develops.

[Q.]How effective is MMR vaccine?

From 95 percent to 98 percent of persons who receive a single dose of MMR
will develop immunity to all three viruses.

[Q.]Why is MMR vaccine given after the first birthday?

Most infants born in the United States will receive passive protection
against measles, mumps, and rubella in the form of maternal antibody. These
antibodies can destroy the vaccine virus if they are present when the vaccine
is administered. By 12 months of age, almost all infants have lost this
passive protection, so the vaccine viruses can replicate and produce infection
with interference.

[Q.]If a single dose of MMR vaccine is so effective, why do we give a second
dose?

The second dose is to provide another chance to develop measles immunity
for persons who did not respond to the first dose. About 2 percent to 5
percent of persons do not develop measles immunity after the first dose of
vaccine.

[Q.]What is the best age to give the second dose of MMR vaccine?

The second dose of MMR can be given anytime, as long as the child is at
least 12 months old and it has been at least a month since the first dose.
However, the second dose is usually administered before the child begins
kindergarten or first grade (4-5 years of age) or before entry to middle
school (11-12 years of age). The age at which the second dose is required is
generally mandated by state school entry requirements.

[Q.]Can I give a PPD (tuberculin skin test) on the same day as a dose of MMR
vaccine?

Live measles vaccine can reduce the reactivity of a PPD because of mild
suppression of the immune system. A PPD can be done before or at the same time
as measles vaccine is given. However, if measles vaccine is given first, the
PPD should be delayed for at least one month.

[Q.]What is the most common adverse event following MMR vaccine?

Low grade fever and a mild rash, which occur in 5 percent to 10 percent of
recipients.

[Q.]For years our clinic has given MMR intramuscularly (IM) rather than
subcutaneously (SC). Is it less effective IM? If MMR has been given IM instead
of SC should it be repeated?
All live injected vaccines (MMR, varicella, and yellow fever) are
recommended to be given subcutaneously. Intramuscular administration is not
likely to decrease immunogenicity, and doses given IM do not need to be
repeated.

[Q.]Why are people born before 1957 exempt to receiving MMR vaccine?

Persons born in 1957 and before lived through several years of epidemic
measles before the first measles vaccine was licensed. As a result, these
people are very likely to have had measles disease. Serologic surveys suggest
that 95%-98% of persons born before 1957 are immune to measles. The "1957
rule" applies only to measles and mumps, and does NOT apply to rubella.

[Q.]How long after a blood transfusion can a person be given MMR vaccine?

MMR should not be given for 6 months following a transfusion of whole
blood. Different blood products require different waiting periods before
giving measles vaccine. Table 8 in the General Recommendations on Immunization
gives a complete listing of these intervals.

[Q.]Rubella is a very mild disease. Why do we even bother to vaccinate against
it?

Rubella disease in childhood is usually a mild illness. The major public
health importance of rubella is the impact the virus may have on a developing
fetus. If a woman is infected with rubella virus during the first trimester of
pregnancy, the fetus may be stillborn, or may be born with severe birth
defects, such as blindness, deafness, or mental retardation. These defects in
a newborn of a woman who has rubella during pregnancy are collectively known
as congenital rubella syndrome.

[Q.]How common is arthritis following rubella vaccine?

Joint pain is reported by 25